The down-regulation of Bcl-2 and up-regulation of Bax, Caspase-9, and Caspase-3 protein expression in cancerous cells may draw attention to thymol as a potential candidate for the development of future gastric adenocarcinomas treatment strategies. The gene discussed is CASP9; the disease is gastric adenocarcinoma.